Elimination of the DATA-Waiver Program: How will it Impact the Opioid Crisis?
Have you heard about the signing of the Consolidated Appropriations Act of 2023? With this Act, Congress eliminated the DATA-Waiver Program. This means: A DATA-Waiver
Have you heard about the signing of the Consolidated Appropriations Act of 2023? With this Act, Congress eliminated the DATA-Waiver Program. This means: A DATA-Waiver
“Prevention is better than cure,” the Dutch philosopher Desiderius Erasmus once observed. Clearly, Erasmus’ maxim – first mentioned in the 1500s – had staying power:
I have written before about how it is nearly impossible to prevent all diversion. We do the best we can to tighten the chain of
When was the last time you did a gap analysis of your drug diversion program? Was that audit done by an internal team or an
Sovah Health has agreed to pay $4.36 million to settle claims that the hospital system violated the Controlled Substance Act. The violations occurred between 2017
How does the DEA define significant loss? That is a question many of you who oversee controlled substances have asked over the years. I have
How common are verbal orders at your facility? How timely are the physicians authenticating those verbal orders? Does anyone other than the nurse entering the
What kind of evidence do you need to pronounce a guilty verdict when it comes to diversion? Catching someone in the act of placing medication
As healthcare professionals tasked with ensuring patient safety and maintaining the integrity of our institutions, we often encounter cases of suspected drug diversion that aren’t
In the healthcare sector, maintaining patient safety while respecting employee privacy is a delicate balance, especially when it comes to managing professionals with a history
In healthcare, where every penny counts, investing in a diversion mitigation and monitoring program might seem like a non-essential expense. Yet, neglecting this crucial program
© Copyright 2023. All Rights Reserved.